Skip to main content

The FDA may not fully approve a COVID-19 vaccine until January. Here’s why

It looks as though the first full approval of a COVID-19 vaccine will happen by January at the latest, according to the typical timeline for new therapies that are considered a priority by U.S. regulators.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.